Can Epigenetic Therapy Overcome Endocrine Resistance in Breast Cancer?
Scientists have uncovered the cause behind the development of endocrine resistance in breast cancer and proposed potential treatment avenues for patients.
Source: medindia.net
Epigenetic Therapy News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Epigenetic Therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Epigenetic Therapy Today - Breaking & Trending Today
Dr Alumkal on Standard Treatment Options For Patients With HRD-Altered mCRPC
Joshi Alumkal, MD, discusses treatment options for patients with metastatic castrate-resistant prostate cancer harboring homologous recombination deficient alterations, including PARP inhibitors.
Source: onclive.com
Aytu BioPharma, Inc.: Aytu BioPharma Announces Issuance of Its First Patent for AR101/Enzastaurin
First Issued U.S. Patent Covers Methods of Treating a Broad Range of Inherited Aortic Aneurism and Related Conditions Including Vascular Ehlers-Danlos SyndromeMultiple Patent Families Filed in Key Global
Source: finanznachrichten.de
Aytu BioPharma Announces Issuance of Its First Patent for AR101/Enzastaurin
Aytu BioPharma, Inc. today announced that the U.S. Patent and Trademark Office has issued a new patent, No. 11,273,148 (the "'148 patent"), for AR101/Enzastaurin.
Source: biospace.com